# Lisata Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 10-K/A
- Filed: 2022-04-21
- Accepted by EDGAR: Apr 21, 2022, 16:04 ET
- Period: 2021-12-31
- Accession: 0000320017-22-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001722000025/clbs-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001722000025/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001722000025/clbs-20211231.htm

Filed Apr 21, 2022.
Source: SEC EDGAR, the filing index for accession 0000320017-22-000025. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
